OVERVIEW
With the Vaccines on Demand program, BARDA'S DRIVe and the Division of CBRN MCMs are seeking innovative technologies that advance the capability for manufacturing vaccines on demand at the point-of-service.
Vaccines are critical medical countermeasures for infectious disease threats. To facilitate the rapid production of vaccines during outbreaks/pandemics, progress toward decentralized vaccine manufacturing is needed.
PARTNERS
Companies we have partnered with on this program to date
APPROACH
Support the development of Vaccines on Demand technologies/systems for distributed vaccine production at or near the point-of-service.
We are specifically interested in platforms that have:
- Easily definable inputs
- Logistically useful footprint
- Minimal to no release testing
- Small-scale validation
- In-line formulation capabilities
- Plug and play capability
Next generation COVID-19 vaccine candidates utilizing any of the following platforms will be considered:
- mRNA
- Recombinant protein
- Virus-like particle
- Viral vector
Program Goals
Create Next Generation Vaccines
Allow for flexible design and rapid production
>1000 Doses Per Batch
Ensure large-batch capability for prompt response
One Batch Within Seven Days
Optimize End to End Production Cycle
Looking for General FAQ?
Vaccines on Demand is paused.